VistaGen Therapeutics Inc.

(NASDAQ:VTGN)

Collapse Summary General Information
 Location South San Francisco, Calif.
 Region San Francisco Bay Area
 Country U.S.
 Business Category ADMET, Gene/Cell therapy, Neurology
 Year Founded 1998
 Website http://www.vistagen.com
 Lead Product Status Phase II
Get a free BioCentury trial today
 Archive Items are loading loading
 Financial Information
 
 Earnings Summary
 Stocks Annual Chart
Week of 11/17/2017 - 479,954 Week of 11/10/2017 - 901,209 Week of 11/03/2017 - 699,036 Week of 10/27/2017 - 6,407,806 Week of 10/20/2017 - 342,522 Week of 10/13/2017 - 320,408 Week of 10/06/2017 - 153,220 Week of 09/29/2017 - 352,951 Week of 09/22/2017 - 84,586 Week of 09/15/2017 - 162,801 Week of 09/08/2017 - 405,761 Week of 09/01/2017 - 190,134 Week of 08/25/2017 - 146,588 Week of 08/18/2017 - 197,780 Week of 08/11/2017 - 272,580 Week of 08/04/2017 - 326,958 Week of 07/28/2017 - 372,294 Week of 07/21/2017 - 172,798 Week of 07/14/2017 - 492,255 Week of 07/07/2017 - 95,061 Week of 06/30/2017 - 300,378 Week of 06/23/2017 - 174,639 Week of 06/16/2017 - 151,350 Week of 06/09/2017 - 197,546 Week of 06/02/2017 - 151,546 Week of 05/26/2017 - 175,419 Week of 05/19/2017 - 208,567 Week of 05/12/2017 - 217,479 Week of 05/05/2017 - 329,791 Week of 04/28/2017 - 118,954 Week of 04/21/2017 - 131,043 Week of 04/14/2017 - 84,055 Week of 04/07/2017 - 136,906 Week of 03/31/2017 - 609,254 Week of 03/24/2017 - 116,536 Week of 03/17/2017 - 313,231 Week of 03/10/2017 - 298,565 Week of 03/03/2017 - 219,667 Week of 02/24/2017 - 358,810 Week of 02/17/2017 - 389,574 Week of 02/10/2017 - 360,680 Week of 02/03/2017 - 181,112 Week of 01/27/2017 - 207,347 Week of 01/20/2017 - 174,133 Week of 01/13/2017 - 226,359 Week of 01/06/2017 - 90,211 Week of 12/30/2016 - 60,326 Week of 12/23/2016 - 156,519 Week of 12/16/2016 - 226,735 Week of 12/09/2016 - 130,412 Week of 12/02/2016 - 55,833 Week of 11/25/2016 - 142,095
 Pipeline Information
 
 Deals Information